data_1a23_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1a23 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 122.355 1.074 . . . . 4.1799999999999997 109.96 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -123.48 89.79 3.16 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.457 -2.053 . . . . 5.3099999999999996 105.457 178.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 80.48 105.44 0.07 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 113.755 -1.566 . . . . 2.77 109.105 -177.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -125.82 50.3 1.86 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.951 0.882 . . . . 2.9500000000000002 109.959 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 52.9 90.93 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.973 -0.558 . . . . 2.54 110.203 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.82 -19.0 21.64 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 110.637 -0.985 . . . . 1.2 110.637 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -68.79 0.64 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.691 -1.226 . . . . 3.3199999999999998 107.691 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -100.21 -22.09 15.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.105 -0.372 . . . . 4.1500000000000004 110.895 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 1.5 p90 -154.81 119.76 4.91 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.821 0.82 . . . . 2.3100000000000001 110.086 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.514 HG21 ' CG ' ' A' ' 160' ' ' GLN . 6.2 t -101.14 163.39 12.3 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.181 -1.044 . . . . 1.3400000000000001 108.181 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.0 m -97.87 143.13 28.79 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.226 0.536 . . . . 1.55 110.261 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' A' ' 154' ' ' PHE . 2.6 mt -84.7 153.77 22.88 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.035 -0.53 . . . . 1.9099999999999999 109.728 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -83.0 -20.26 35.42 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.5 -0.926 . . . . 3.3199999999999998 108.5 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -125.62 100.95 30.86 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 109.605 -0.517 . . . . 3.3100000000000001 109.605 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 37.3 Cg_endo -79.52 157.93 25.39 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.682 1.588 . . . . 1.3400000000000001 109.093 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.1 t -119.85 104.92 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.314 0.578 . . . . 2.04 109.783 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 127.39 31.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.931 -1.137 . . . . 2.0099999999999998 107.931 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.63 -14.7 64.71 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.373 -1.491 . . . . 1.2 109.373 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.36 158.61 0.31 Allowed Pre-proline 0 N--CA 1.507 2.387 0 CA-C-N 117.935 0.868 . . . . 1.3600000000000001 111.045 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.464 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -78.85 140.12 16.01 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.289 1.993 . . . . 1.03 110.567 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -53.02 -20.0 3.16 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 116.106 -0.497 . . . . 2.6499999999999999 110.812 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 54.1 t -153.21 80.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.066 -1.087 . . . . 1.27 108.066 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.464 ' HG ' ' CG ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -76.4 112.84 13.33 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.944 -1.502 . . . . 1.28 106.944 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -100.13 132.23 45.61 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.444 -0.576 . . . . 2.0499999999999998 109.444 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -118.3 119.23 34.01 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.223 -0.658 . . . . 2.04 109.223 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -155.84 143.57 19.6 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.827 -0.749 . . . . 2.2599999999999998 109.662 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.3 p -118.47 167.12 11.89 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.238 -0.653 . . . . 1.6299999999999999 109.238 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.505 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 4.5 m-30 -91.66 53.07 2.16 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.667 -1.605 . . . . 2.2599999999999998 106.667 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.424 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 8.8 m-85 -150.97 7.25 0.53 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.429 -0.805 . . . . 2.5800000000000001 111.227 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.2 m -112.35 164.69 14.66 Favored Pre-proline 0 N--CA 1.495 1.796 0 CA-C-N 119.352 0.978 . . . . 1.49 110.124 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.16 -34.33 2.21 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 121.712 1.608 . . . . 0.83999999999999997 108.322 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 36' ' ' PHE . 69.9 m80 -73.73 -39.79 64.02 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 107.448 -1.315 . . . . 3.6099999999999999 107.448 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 32' ' ' HIS . 6.5 t -29.57 -63.62 0.12 Allowed 'General case' 0 N--CA 1.52 3.031 0 CA-C-O 121.886 0.851 . . . . 2.0600000000000001 110.685 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.532 ' HB2' ' OE1' ' A' ' 97' ' ' GLN . 16.1 t80 -66.29 -55.73 14.63 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.012 -0.995 . . . . 2.3999999999999999 110.179 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -58.08 -18.97 28.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.631 -0.259 . . . . 2.4900000000000002 111.165 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -87.22 -40.51 14.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.024 -0.422 . . . . 3.1499999999999999 110.283 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.14 8.28 25.9 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.936 -0.478 . . . . 2.46 112.161 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 3.6 mm-40 -132.58 -40.82 0.97 Allowed 'General case' 0 N--CA 1.514 2.733 0 N-CA-C 113.654 0.983 . . . . 2.04 113.654 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.63 -70.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.23 -0.919 . . . . 1.6599999999999999 111.017 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.44 -23.44 38.7 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 122.097 -0.377 . . . . 1.8100000000000001 111.634 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 59.11 18.84 6.77 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.839 -0.538 . . . . 3.0899999999999999 110.098 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.0 mt -55.94 -23.0 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 121.436 -0.79 . . . . 1.55 110.083 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.82 -48.04 11.22 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 109.583 -0.525 . . . . 1.73 109.583 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.27 -28.57 57.12 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.803 -0.443 . . . . 2.71 109.803 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -69.51 -40.3 77.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.171 -0.33 . . . . 2.3300000000000001 110.61 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 7.5 m -68.72 -35.38 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.664 -0.814 . . . . 2.3300000000000001 109.082 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -55.56 -38.42 69.31 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.956 -0.387 . . . . 2.5899999999999999 109.956 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -37.11 65.96 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.886 -0.783 . . . . 4.1600000000000001 108.886 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -103.19 33.25 3.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.8 -0.636 . . . . 3.5699999999999998 110.943 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 56' ' ' MET . 19.9 mt -108.33 92.7 10.13 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.583 -0.698 . . . . 2.0600000000000001 109.198 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -75.27 149.04 35.08 Favored 'Trans proline' 0 N--CA 1.484 0.929 0 C-N-CA 122.144 1.896 . . . . 1.8400000000000001 110.612 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -44.32 120.21 2.1 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.72 0.771 . . . . 3.6000000000000001 110.563 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.21 -19.83 5.98 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.173 -1.171 . . . . 1.8200000000000001 110.173 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.1 t -98.5 97.18 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.854 -0.792 . . . . 2.2200000000000002 109.205 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -77.36 99.31 5.52 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.015 0.436 . . . . 3.4300000000000002 110.049 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.44 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 10.3 ttt -93.16 102.11 14.41 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.498 -0.927 . . . . 2.77 108.498 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.36 142.06 33.32 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.517 -0.765 . . . . 1.23 109.118 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 113.65 20.76 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.587 -1.264 . . . . 2.96 107.587 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 4.0 m-85 -118.09 161.28 20.1 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.899 0.857 . . . . 2.1899999999999999 112.129 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.458 ' NE2' ' CD2' ' A' ' 72' ' ' LEU . 55.6 t-80 -98.53 146.32 25.91 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.089 -0.96 . . . . 2.3199999999999998 110.296 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.411 ' CG1' HD22 ' A' ' 147' ' ' LEU . 3.3 m -96.33 156.63 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 115.042 -0.981 . . . . 2.0499999999999998 110.827 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 70' ' ' LYS . 7.1 p-10 -127.53 48.25 2.26 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.013 0.911 . . . . 2.3700000000000001 108.874 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -140.73 57.24 1.57 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.601 -1.629 . . . . 2.7000000000000002 106.601 178.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 64' ' ' MET . 1.1 tpt -151.5 54.61 0.85 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.155 0.979 . . . . 3.9100000000000001 109.836 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.5 -46.34 0.9 Allowed Glycine 0 N--CA 1.499 2.893 0 N-CA-C 109.544 -1.423 . . . . 2.3900000000000001 109.544 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.28 -39.9 2.95 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.716 -0.954 . . . . 2.21 110.716 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.49 -80.22 0.26 Allowed 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 117.902 0.851 . . . . 2.0299999999999998 110.69 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.37 -21.89 45.16 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.376 -0.529 . . . . 1.8 110.562 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 68' ' ' LEU . . . -59.19 -37.65 92.07 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 108.584 -1.806 . . . . 0.55000000000000004 108.584 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HG2' ' HB2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -69.92 -43.8 70.94 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.747 -0.835 . . . . 3.46 108.747 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.81 -27.82 63.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.863 -0.792 . . . . 1.6699999999999999 108.863 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' CD2' ' NE2' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -69.45 -29.3 66.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.846 -1.168 . . . . 1.9199999999999999 107.846 178.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.85 -43.13 94.01 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.851 -2.277 . . . . 1.1000000000000001 104.851 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 16.8 tt0 -60.64 -23.25 64.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.715 -1.217 . . . . 1.54 107.715 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 72' ' ' LEU . . . -63.96 -48.72 75.37 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.986 -1.116 . . . . 1.2 107.986 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.425 ' HB3' ' OE1' ' A' ' 138' ' ' GLN . 36.3 t-105 -55.83 -34.78 65.7 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.467 -0.568 . . . . 1.01 109.467 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -79.36 -50.41 10.89 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.037 -0.665 . . . . 1.1299999999999999 110.518 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' CG1' ' CD2' ' A' ' 122' ' ' TYR . 11.4 t -64.79 -26.75 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 122.093 -0.38 . . . . 1.48 110.565 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.9 -52.68 6.48 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.684 -0.858 . . . . 1.1100000000000001 108.684 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.7 ttt -54.64 -25.98 30.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.751 -0.833 . . . . 2.1299999999999999 108.751 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 131' ' ' VAL . . . -68.77 -47.14 66.94 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.689 -0.486 . . . . 1.1299999999999999 109.689 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.9 mt -99.94 6.47 45.18 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.211 -0.306 . . . . 1.1799999999999999 111.069 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.23 21.17 52.93 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.449 -1.46 . . . . 0.56000000000000005 109.449 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.07 5.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 122.098 -0.648 . . . . 1.1599999999999999 110.505 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' OE1' ' CH2' ' A' ' 76' ' ' TRP . 26.5 tt0 -49.82 -66.59 0.37 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.209 -0.663 . . . . 2.0699999999999998 109.209 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.72 -35.35 1.8 Allowed 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 122.376 0.27 . . . . 1.3600000000000001 111.404 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -78.58 -53.09 7.56 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 122.133 -0.354 . . . . 2.6099999999999999 111.578 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 m -82.2 -11.41 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 O-C-N 121.8 -0.562 . . . . 1.1200000000000001 110.949 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.513 HG21 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -71.85 -44.35 63.97 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.595 -0.891 . . . . 1.1499999999999999 108.595 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -56.1 -55.91 36.67 Favored Pre-proline 0 N--CA 1.501 2.12 0 CA-C-O 118.359 -0.829 . . . . 1.21 110.211 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -70.09 -19.31 34.7 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.377 1.198 . . . . 0.42999999999999999 110.647 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 19.8 mt -85.49 -45.08 12.15 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.961 -0.755 . . . . 1.1000000000000001 108.961 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.513 ' CD1' HG21 ' A' ' 89' ' ' THR . 4.0 m-30 -62.25 -48.04 81.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.887 -0.783 . . . . 2.1000000000000001 108.887 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.54 -25.04 61.23 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.126 -0.488 . . . . 2.1800000000000002 110.086 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.78 -27.85 62.08 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 111.116 -0.793 . . . . 0.40999999999999998 111.116 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.471 HG21 HG13 ' A' ' 102' ' ' ILE . 2.2 t -96.02 -15.13 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 118.329 1.065 . . . . 1.1100000000000001 110.196 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.532 ' OE1' ' HB2' ' A' ' 34' ' ' TYR . 25.2 mt-30 -112.55 1.84 16.01 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.073 -1.051 . . . . 2.79 113.432 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.42 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -152.48 47.41 0.74 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 119.583 1.083 . . . . 3.6200000000000001 109.214 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER -179.33 -48.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 115.959 -0.564 . . . . 1.8200000000000001 109.884 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 99' ' ' THR . 3.2 mt-30 70.88 18.03 6.2 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 120.934 0.397 . . . . 2.0800000000000001 110.1 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.7 t -82.78 -6.66 59.52 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.756 -0.831 . . . . 1.8300000000000001 108.756 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.471 HG13 HG21 ' A' ' 96' ' ' VAL . 15.4 mm -90.1 79.06 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.977 -0.749 . . . . 1.1699999999999999 108.977 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.98 25.78 1.91 Allowed 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.543 -0.723 . . . . 3.9399999999999999 109.239 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.4 p -150.24 133.83 16.61 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.305 -0.628 . . . . 0.95999999999999996 109.305 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.82 -33.47 35.98 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.325 -0.991 . . . . 1.23 108.325 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.5 p -62.94 -33.62 75.74 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.392 -0.966 . . . . 1.8300000000000001 108.392 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -49.79 62.1 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.836 -1.172 . . . . 1.9399999999999999 107.836 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.436 HD13 HD21 ' A' ' 68' ' ' LEU . 43.4 mt -49.45 -30.17 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 N-CA-C 109.04 -0.726 . . . . 1.2 109.04 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -74.2 -39.56 63.06 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.414 -0.587 . . . . 3.1699999999999999 109.414 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.95 -45.08 78.93 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.523 -0.547 . . . . 2.21 109.523 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.449 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 21.7 t -71.86 -38.98 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 109.629 -0.508 . . . . 1.24 109.629 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -47.82 84.05 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.182 -0.673 . . . . 2.3300000000000001 109.182 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.96 -25.71 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.724 -0.472 . . . . 1.23 109.724 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -25.8 68.19 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.835 -0.431 . . . . 2.1699999999999999 109.835 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.9 6.84 33.64 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.991 -0.443 . . . . 1.1399999999999999 110.256 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.12 7.21 73.94 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.996 -1.242 . . . . 0.71999999999999997 109.996 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -90.72 64.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.2 -1.408 . . . . 1.51 107.2 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -41.71 147.44 0.2 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.415 -0.803 . . . . 3.0699999999999998 110.918 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.31 -26.72 14.42 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 109.643 -1.383 . . . . 0.68000000000000005 109.643 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -64.06 -47.94 78.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 122.276 -0.543 . . . . 2.3999999999999999 109.67 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.83 -37.82 47.67 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.441 -0.577 . . . . 2.1699999999999999 109.441 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.487 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 4.4 t80 -64.03 -51.12 65.66 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.61 -0.885 . . . . 2.3199999999999998 108.61 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -61.97 -38.28 87.96 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.002 -0.74 . . . . 1.95 109.002 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.87 86.75 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.677 -0.86 . . . . 1.22 108.677 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.15 -54.3 48.29 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.689 -0.856 . . . . 1.05 108.689 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.415 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 13.9 t90 -53.53 -54.71 33.36 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.601 -0.889 . . . . 3.1499999999999999 108.601 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -57.68 -16.55 11.13 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 116.012 -0.54 . . . . 1.6299999999999999 111.104 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.6 m -74.64 -178.19 3.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.588 -0.695 . . . . 1.5600000000000001 109.734 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.57 -40.7 11.8 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.832 -0.622 . . . . 3.9500000000000002 111.1 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.46 -46.79 91.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.625 -0.83 . . . . 1.3799999999999999 110.212 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 81' ' ' ALA . 6.5 t -66.78 -37.08 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.7 -0.852 . . . . 1.49 108.7 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -68.59 -37.0 79.46 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.898 -0.779 . . . . 2.9500000000000002 108.898 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.57 -33.97 76.02 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.901 -0.777 . . . . 1.8700000000000001 108.901 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.57 -26.12 45.5 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.582 -0.895 . . . . 1.9299999999999999 108.582 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.419 HG21 ' CB ' ' A' ' 77' ' ' ALA . 15.5 t -73.8 -48.28 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.3 -1.37 . . . . 1.3400000000000001 107.3 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.69 -57.3 13.34 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.815 -0.809 . . . . 1.26 108.815 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.26 -21.61 62.09 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.407 -0.59 . . . . 2.9700000000000002 109.407 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.425 ' OE1' ' HB3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -71.74 -65.39 0.77 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.37 -0.974 . . . . 3.3700000000000001 108.37 179.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -52.96 -30.55 35.44 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.748 -0.834 . . . . 2.5600000000000001 108.748 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -72.56 -51.21 20.78 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.465 -0.939 . . . . 3.1499999999999999 108.465 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -42.07 -56.95 2.64 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 120.889 0.376 . . . . 1.1899999999999999 110.592 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.94 -24.34 62.41 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.591 -0.443 . . . . 1.29 110.104 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -84.97 -21.13 29.66 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.874 -0.516 . . . . 1.49 111.49 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.38 -52.02 6.51 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.746 -1.205 . . . . 2.23 107.746 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 30.8 m -80.77 -20.75 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.354 -0.609 . . . . 1.3200000000000001 109.354 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.6 OUTLIER 86.4 -43.65 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 123.079 0.552 . . . . 2.5699999999999998 109.598 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.411 HD22 ' CG1' ' A' ' 61' ' ' VAL . 56.6 tp 65.35 137.95 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.402 -0.962 . . . . 1.3100000000000001 108.402 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.59 26.15 0.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 4.7000000000000002 111.938 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.98 105.14 0.18 Allowed Glycine 0 N--CA 1.503 3.102 0 C-N-CA 119.908 -1.139 . . . . 0.75 110.977 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.408 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -87.19 139.51 32.29 Favored Pre-proline 0 N--CA 1.506 2.35 0 O-C-N 122.323 -0.516 . . . . 1.4099999999999999 109.78 178.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -76.58 147.47 86.86 Favored 'Cis proline' 0 CA--C 1.545 1.028 0 O-C-N 123.193 1.102 . . . . 0.70999999999999996 109.86 -0.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -131.47 150.07 52.29 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.183 -1.043 . . . . 1.26 108.183 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -139.63 139.66 36.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.239 -0.585 . . . . 3.04 109.951 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' A' ' 12' ' ' LEU . 69.6 m-85 -130.84 119.52 22.35 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.576 -0.527 . . . . 2.2599999999999998 109.576 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.3 t -91.59 125.13 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 109.196 -0.668 . . . . 1.1799999999999999 109.196 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.4 t30 50.04 23.07 1.02 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.421 -0.809 . . . . 2.2599999999999998 110.314 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 54.8 53.9 36.63 Favored Glycine 0 N--CA 1.503 3.165 0 N-CA-C 108.575 -1.81 . . . . 0.81000000000000005 108.575 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.454 ' HG3' ' HB3' ' A' ' 15' ' ' PRO . 1.4 tttt -159.19 -32.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.643 -0.502 . . . . 2.46 109.643 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.412 ' CD1' ' HB3' ' A' ' 158' ' ' LYS . 44.6 m-85 -129.27 120.43 25.67 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.945 -0.702 . . . . 2.4500000000000002 109.498 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.514 ' CG ' HG21 ' A' ' 10' ' ' THR . 14.3 pt20 -104.04 131.03 51.72 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.771 -0.455 . . . . 2.2799999999999998 109.771 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 17.4 mt -68.08 178.18 1.94 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 106.856 -1.535 . . . . 1.55 106.856 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -146.97 92.6 4.94 Favored Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 118.045 -1.462 . . . . 2.7599999999999998 113.923 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -85.31 14.91 2.34 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.428 2.085 . . . . 2.0099999999999998 108.132 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.41 -27.34 0.15 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.883 1.273 . . . . 4.3499999999999996 113.583 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.32 52.29 0.29 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.639 -1.267 . . . . 4.3399999999999999 111.663 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.87 89.03 3.05 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.195 0.998 . . . . 6.0300000000000002 112.076 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -145.84 63.9 1.24 Allowed 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 105.691 -1.966 . . . . 5.2999999999999998 105.691 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.4 p -95.14 -87.54 0.27 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.483 -0.761 . . . . 4.4299999999999997 112.28 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.47 26.52 0.08 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.374 -0.828 . . . . 3.3900000000000001 109.92 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -149.81 86.98 1.46 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 120.119 -0.632 . . . . 3.5499999999999998 110.187 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 49.0 mtt -68.68 -17.71 64.13 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.008 -1.478 . . . . 2.75 107.008 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -61.17 2.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.217 -0.66 . . . . 2.1099999999999999 109.217 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 25.7 t -58.29 -38.63 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.763 -0.828 . . . . 1.8400000000000001 108.763 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 174' ' ' PHE . 8.6 t80 -59.48 -49.47 77.68 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.843 -0.799 . . . . 3.3900000000000001 108.843 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.84 -29.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 122.019 -0.426 . . . . 1.4399999999999999 110.623 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -82.56 -53.84 5.64 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.281 -0.637 . . . . 2.7000000000000002 109.281 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 0.8 OUTLIER -59.37 -40.42 86.42 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.719 -0.845 . . . . 3.25 108.719 179.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 5.0 t80 -62.6 -54.76 34.85 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.245 -1.021 . . . . 2.3700000000000001 108.245 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.78 -28.5 66.01 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.749 -0.463 . . . . 1.4199999999999999 109.749 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.31 -38.88 60.06 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.595 -0.52 . . . . 2.04 109.595 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.4 -39.22 91.94 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.809 -0.811 . . . . 1.6699999999999999 108.809 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.91 -34.85 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 109.585 -0.524 . . . . 1.3999999999999999 109.585 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -60.51 -52.31 65.72 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.337 -0.616 . . . . 2.9300000000000002 109.337 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -36.84 64.56 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.566 -0.901 . . . . 2.3500000000000001 108.566 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 185' ' ' LEU . 0.5 OUTLIER -57.2 -22.76 43.0 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.834 -0.802 . . . . 1.5 108.834 -179.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 51.4 p -68.94 -28.91 67.07 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.098 -1.075 . . . . 1.8 108.098 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -92.54 24.77 3.33 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.627 -0.879 . . . . 2.6800000000000002 108.627 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.5 -43.97 93.23 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.428 -0.509 . . . . 3.96 112.045 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.4 pttp . . . . . 0 N--CA 1.501 2.09 0 CA-C-O 118.499 -0.762 . . . . 5.6799999999999997 111.343 -177.355 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.735 ' HB1' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 122.355 1.074 . . . . 3.68 109.96 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -123.48 89.79 3.16 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.457 -2.053 . . . . 4.74 105.457 178.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 80.48 105.44 0.07 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 113.755 -1.566 . . . . 2.18 109.105 -177.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.735 ' HG3' ' HB1' ' A' ' 1' ' ' ALA . 23.8 mt-10 -125.82 50.3 1.86 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.951 0.882 . . . . 2.95 109.959 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 52.9 90.93 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.973 -0.558 . . . . 2.54 110.203 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.82 -19.0 21.64 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 110.637 -0.985 . . . . 1.2 110.637 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -68.79 0.64 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.691 -1.226 . . . . 2.95 107.691 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -100.21 -22.09 15.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.105 -0.372 . . . . 3.41 110.895 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 1.5 p90 -154.81 119.76 4.91 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.821 0.82 . . . . 1.53 110.086 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 t -101.14 163.39 12.3 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.181 -1.044 . . . . 0.85 108.181 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.0 m -97.87 143.13 28.79 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.226 0.536 . . . . 1.04 110.261 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.495 HD21 ' CE1' ' A' ' 154' ' ' PHE . 2.6 mt -84.7 153.77 22.88 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.035 -0.53 . . . . 1.33 109.728 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -83.0 -20.26 35.42 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.5 -0.926 . . . . 3.32 108.5 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -125.62 100.95 30.86 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 109.605 -0.517 . . . . 2.92 109.605 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 37.3 Cg_endo -79.52 157.93 25.39 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.682 1.588 . . . . 1.24 109.093 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.1 t -119.85 104.92 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.314 0.578 . . . . 1.5 109.783 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 127.39 31.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.931 -1.137 . . . . 1.54 107.931 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.63 -14.7 64.71 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.373 -1.491 . . . . 1.15 109.373 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.527 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -45.36 158.61 0.31 Allowed Pre-proline 0 N--CA 1.507 2.387 0 CA-C-N 117.935 0.868 . . . . 0.84 111.045 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -78.85 140.12 16.01 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.289 1.993 . . . . 0.88 110.567 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.524 ' O ' HG13 ' A' ' 155' ' ' VAL . 2.6 mt-30 -53.02 -20.0 3.16 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 116.106 -0.497 . . . . 2.28 110.812 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 54.1 t -153.21 80.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.066 -1.087 . . . . 0.54 108.066 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.757 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -76.4 112.84 13.33 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.944 -1.502 . . . . 0.61 106.944 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -100.13 132.23 45.61 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.444 -0.576 . . . . 2.05 109.444 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.757 ' CE2' HD13 ' A' ' 23' ' ' LEU . 7.8 m-85 -118.3 119.23 34.01 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.223 -0.658 . . . . 1.26 109.223 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -155.84 143.57 19.6 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.827 -0.749 . . . . 1.35 109.662 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.778 ' HB3' HG22 ' A' ' 61' ' ' VAL . 3.3 p -118.47 167.12 11.89 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.238 -0.653 . . . . 1.25 109.238 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.566 ' O ' HG21 ' A' ' 96' ' ' VAL . 4.5 m-30 -91.66 53.07 2.16 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.667 -1.605 . . . . 1.35 106.667 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CG ' HG11 ' A' ' 96' ' ' VAL . 8.8 m-85 -150.97 7.25 0.53 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.429 -0.805 . . . . 1.7 111.227 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 1.2 m -112.35 164.69 14.66 Favored Pre-proline 0 N--CA 1.495 1.796 0 CA-C-N 119.352 0.978 . . . . 1.05 110.124 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.16 -34.33 2.21 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 121.712 1.608 . . . . 0.78 108.322 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 36' ' ' PHE . 69.9 m80 -73.73 -39.79 64.02 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 107.448 -1.315 . . . . 2.92 107.448 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 32' ' ' HIS . 6.5 t -29.57 -63.62 0.12 Allowed 'General case' 0 N--CA 1.52 3.031 0 CA-C-O 121.886 0.851 . . . . 1.67 110.685 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.569 ' HB2' ' OE1' ' A' ' 97' ' ' GLN . 16.1 t80 -66.29 -55.73 14.63 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.012 -0.995 . . . . 1.54 110.179 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -58.08 -18.97 28.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.631 -0.259 . . . . 1.88 111.165 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -87.22 -40.51 14.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.024 -0.422 . . . . 2.26 110.283 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.14 8.28 25.9 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.936 -0.478 . . . . 2.46 112.161 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 3.6 mm-40 -132.58 -40.82 0.97 Allowed 'General case' 0 N--CA 1.514 2.733 0 N-CA-C 113.654 0.983 . . . . 2.04 113.654 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.63 -70.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.23 -0.919 . . . . 1.17 111.017 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.44 -23.44 38.7 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 122.097 -0.377 . . . . 1.27 111.634 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 59.11 18.84 6.77 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.839 -0.538 . . . . 2.67 110.098 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.77 ' O ' HG13 ' A' ' 46' ' ' VAL . 32.0 mt -55.94 -23.0 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 121.436 -0.79 . . . . 0.88 110.083 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.82 -48.04 11.22 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 109.583 -0.525 . . . . 1.2 109.583 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.27 -28.57 57.12 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.803 -0.443 . . . . 2.71 109.803 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -69.51 -40.3 77.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.171 -0.33 . . . . 2.21 110.61 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 42' ' ' ILE . 7.5 m -68.72 -35.38 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.664 -0.814 . . . . 1.69 109.082 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.644 ' HA ' HD12 ' A' ' 50' ' ' LEU . 11.1 mttt -55.56 -38.42 69.31 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.956 -0.387 . . . . 2.11 109.956 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -37.11 65.96 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.886 -0.783 . . . . 3.72 108.886 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 20.4 mttt -103.19 33.25 3.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.8 -0.636 . . . . 3.17 110.943 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 47' ' ' LYS . 19.9 mt -108.33 92.7 10.13 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.583 -0.698 . . . . 1.62 109.198 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 32.9 Cg_endo -75.27 149.04 35.08 Favored 'Trans proline' 0 N--CA 1.484 0.929 0 C-N-CA 122.144 1.896 . . . . 1.84 110.612 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -44.32 120.21 2.1 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.72 0.771 . . . . 3.6 110.563 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.21 -19.83 5.98 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.173 -1.171 . . . . 1.34 110.173 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.625 HG22 ' HB2' ' A' ' 186' ' ' SER . 4.1 t -98.5 97.18 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.854 -0.792 . . . . 1.73 109.205 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -77.36 99.31 5.52 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.015 0.436 . . . . 2.91 110.049 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.504 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 10.3 ttt -93.16 102.11 14.41 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.498 -0.927 . . . . 2.26 108.498 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.36 142.06 33.32 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.517 -0.765 . . . . 0.56 109.118 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 113.65 20.76 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.587 -1.264 . . . . 2.48 107.587 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 4.0 m-85 -118.09 161.28 20.1 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.899 0.857 . . . . 1.28 112.129 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.676 ' NE2' HD23 ' A' ' 72' ' ' LEU . 55.6 t-80 -98.53 146.32 25.91 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.089 -0.96 . . . . 1.5 110.296 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.778 HG22 ' HB3' ' A' ' 27' ' ' SER . 3.3 m -96.33 156.63 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 115.042 -0.981 . . . . 1.44 110.827 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 70' ' ' LYS . 7.1 p-10 -127.53 48.25 2.26 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.013 0.911 . . . . 1.93 108.874 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -140.73 57.24 1.57 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.601 -1.629 . . . . 1.8 106.601 178.211 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.423 ' O ' ' HG3' ' A' ' 64' ' ' MET . 1.1 tpt -151.5 54.61 0.85 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.155 0.979 . . . . 3.48 109.836 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.5 -46.34 0.9 Allowed Glycine 0 N--CA 1.499 2.893 0 N-CA-C 109.544 -1.423 . . . . 2.39 109.544 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.28 -39.9 2.95 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.716 -0.954 . . . . 1.8 110.716 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.49 -80.22 0.26 Allowed 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 117.902 0.851 . . . . 2.03 110.69 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.712 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.37 -21.89 45.16 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.376 -0.529 . . . . 1.24 110.562 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.712 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -59.19 -37.65 92.07 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 108.584 -1.806 . . . . 0.49 108.584 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -69.92 -43.8 70.94 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.747 -0.835 . . . . 3.07 108.747 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.81 -27.82 63.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.863 -0.792 . . . . 1.67 108.863 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.748 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -69.45 -29.3 66.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.846 -1.168 . . . . 1.22 107.846 178.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.85 -43.13 94.01 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.851 -2.277 . . . . 0.43 104.851 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.843 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.1 tt0 -60.64 -23.25 64.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.715 -1.217 . . . . 1.54 107.715 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.96 -48.72 75.37 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.986 -1.116 . . . . 0.49 107.986 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 36.3 t-105 -55.83 -34.78 65.7 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.467 -0.568 . . . . 0.85 109.467 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.36 -50.41 10.89 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.037 -0.665 . . . . 0.51 110.518 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.889 HG11 ' CD2' ' A' ' 122' ' ' TYR . 11.4 t -64.79 -26.75 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 122.093 -0.38 . . . . 0.83 110.565 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.9 -52.68 6.48 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.684 -0.858 . . . . 0.39 108.684 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.7 ttt -54.64 -25.98 30.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.751 -0.833 . . . . 1.51 108.751 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.881 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -68.77 -47.14 66.94 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.689 -0.486 . . . . 0.45 109.689 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 84' ' ' VAL . 38.9 mt -99.94 6.47 45.18 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.211 -0.306 . . . . 0.51 111.069 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.23 21.17 52.93 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.449 -1.46 . . . . 0.51 109.449 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.593 HG11 ' CG1' ' A' ' 117' ' ' ILE . 28.1 m -88.07 5.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 122.098 -0.648 . . . . 0.43 110.505 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' OE1' ' CH2' ' A' ' 76' ' ' TRP . 26.5 tt0 -49.82 -66.59 0.37 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.209 -0.663 . . . . 2.07 109.209 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.72 -35.35 1.8 Allowed 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 122.376 0.27 . . . . 1.36 111.404 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -78.58 -53.09 7.56 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 122.133 -0.354 . . . . 2.1 111.578 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.644 HG23 HD12 ' A' ' 92' ' ' LEU . 1.8 m -82.2 -11.41 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 O-C-N 121.8 -0.562 . . . . 0.38 110.949 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.71 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -71.85 -44.35 63.97 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.595 -0.891 . . . . 0.46 108.595 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -56.1 -55.91 36.67 Favored Pre-proline 0 N--CA 1.501 2.12 0 CA-C-O 118.359 -0.829 . . . . 0.53 110.211 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.643 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.1 Cg_endo -70.09 -19.31 34.7 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.377 1.198 . . . . 0.39 110.647 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' A' ' 111' ' ' VAL . 19.8 mt -85.49 -45.08 12.15 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.961 -0.755 . . . . 0.41 108.961 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' A' ' 89' ' ' THR . 4.0 m-30 -62.25 -48.04 81.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.887 -0.783 . . . . 1.24 108.887 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.54 -25.04 61.23 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.126 -0.488 . . . . 2.18 110.086 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.78 -27.85 62.08 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 111.116 -0.793 . . . . 0.37 111.116 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.2 t -96.02 -15.13 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 118.329 1.065 . . . . 0.49 110.196 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' OE1' ' HB2' ' A' ' 34' ' ' TYR . 25.2 mt-30 -112.55 1.84 16.01 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.073 -1.051 . . . . 2.3 113.432 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.808 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -152.48 47.41 0.74 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 119.583 1.083 . . . . 3.3 109.214 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.808 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -179.33 -48.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 115.959 -0.564 . . . . 1.27 109.884 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 99' ' ' THR . 3.2 mt-30 70.88 18.03 6.2 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 120.934 0.397 . . . . 1.71 110.1 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.7 t -82.78 -6.66 59.52 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.756 -0.831 . . . . 1.39 108.756 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.651 HG23 ' OD1' ' A' ' 107' ' ' ASP . 15.4 mm -90.1 79.06 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.977 -0.749 . . . . 0.44 108.977 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.98 25.78 1.91 Allowed 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.543 -0.723 . . . . 3.32 109.239 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.4 p -150.24 133.83 16.61 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.305 -0.628 . . . . 0.71 109.305 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.723 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -51.82 -33.47 35.98 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.325 -0.991 . . . . 0.59 108.325 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.5 p -62.94 -33.62 75.74 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.392 -0.966 . . . . 1.42 108.392 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.651 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -67.45 -49.79 62.1 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.836 -1.172 . . . . 1.94 107.836 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 105' ' ' ALA . 43.4 mt -49.45 -30.17 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 N-CA-C 109.04 -0.726 . . . . 0.53 109.04 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -74.2 -39.56 63.06 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.414 -0.587 . . . . 2.69 109.414 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.95 -45.08 78.93 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.523 -0.547 . . . . 2.21 109.523 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.807 HG11 ' HG ' ' A' ' 92' ' ' LEU . 21.7 t -71.86 -38.98 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 109.629 -0.508 . . . . 0.54 109.629 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -47.82 84.05 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.182 -0.673 . . . . 1.43 109.182 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.96 -25.71 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.724 -0.472 . . . . 0.49 109.724 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -25.8 68.19 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.835 -0.431 . . . . 1.72 109.835 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.9 6.84 33.64 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.991 -0.443 . . . . 0.63 110.256 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.12 7.21 73.94 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.996 -1.242 . . . . 0.72 109.996 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.648 HG22 ' HB2' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -90.72 64.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.2 -1.408 . . . . 0.91 107.2 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -41.71 147.44 0.2 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.415 -0.803 . . . . 2.69 110.918 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.31 -26.72 14.42 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 109.643 -1.383 . . . . 0.6 109.643 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -64.06 -47.94 78.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 122.276 -0.543 . . . . 2.4 109.67 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.83 -37.82 47.67 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.441 -0.577 . . . . 2.17 109.441 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.889 ' CD2' HG11 ' A' ' 78' ' ' VAL . 4.4 t80 -64.03 -51.12 65.66 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.61 -0.885 . . . . 1.45 108.61 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -61.97 -38.28 87.96 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.002 -0.74 . . . . 1.95 109.002 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.87 86.75 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.677 -0.86 . . . . 0.52 108.677 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.648 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -57.15 -54.3 48.29 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.689 -0.856 . . . . 0.47 108.689 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -53.53 -54.71 33.36 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.601 -0.889 . . . . 2.39 108.601 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -57.68 -16.55 11.13 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 116.012 -0.54 . . . . 1.46 111.104 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.6 m -74.64 -178.19 3.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.588 -0.695 . . . . 1.35 109.734 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.57 -40.7 11.8 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.832 -0.622 . . . . 3.19 111.1 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.46 -46.79 91.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.625 -0.83 . . . . 0.79 110.212 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.881 HG22 ' CB ' ' A' ' 81' ' ' ALA . 6.5 t -66.78 -37.08 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.7 -0.852 . . . . 0.82 108.7 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -68.59 -37.0 79.46 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.898 -0.779 . . . . 2.39 108.898 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.57 -33.97 76.02 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.901 -0.777 . . . . 1.43 108.901 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.57 -26.12 45.5 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.582 -0.895 . . . . 1.36 108.582 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.5 t -73.8 -48.28 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.3 -1.37 . . . . 0.64 107.3 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.69 -57.3 13.34 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.815 -0.809 . . . . 0.6 108.815 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.26 -21.61 62.09 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.407 -0.59 . . . . 2.43 109.407 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.451 ' OE1' ' HB3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -71.74 -65.39 0.77 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.37 -0.974 . . . . 2.63 108.37 179.042 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -52.96 -30.55 35.44 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.748 -0.834 . . . . 2.56 108.748 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -72.56 -51.21 20.78 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.465 -0.939 . . . . 2.61 108.465 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -42.07 -56.95 2.64 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 120.889 0.376 . . . . 0.65 110.592 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.94 -24.34 62.41 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.591 -0.443 . . . . 0.85 110.104 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -84.97 -21.13 29.66 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.874 -0.516 . . . . 1.05 111.49 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.38 -52.02 6.51 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.746 -1.205 . . . . 2.23 107.746 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.748 HG21 ' HE2' ' A' ' 25' ' ' PHE . 30.8 m -80.77 -20.75 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.354 -0.609 . . . . 0.92 109.354 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.6 OUTLIER 86.4 -43.65 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 123.079 0.552 . . . . 2.17 109.598 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 61' ' ' VAL . 56.6 tp 65.35 137.95 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.402 -0.962 . . . . 1.04 108.402 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.59 26.15 0.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 4.08 111.938 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.98 105.14 0.18 Allowed Glycine 0 N--CA 1.503 3.102 0 C-N-CA 119.908 -1.139 . . . . 0.72 110.977 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.519 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -87.19 139.51 32.29 Favored Pre-proline 0 N--CA 1.506 2.35 0 O-C-N 122.323 -0.516 . . . . 0.92 109.78 178.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -76.58 147.47 86.86 Favored 'Cis proline' 0 CA--C 1.545 1.028 0 O-C-N 123.193 1.102 . . . . 0.63 109.86 -0.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -131.47 150.07 52.29 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.183 -1.043 . . . . 0.57 108.183 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.475 ' SD ' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -139.63 139.66 36.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.239 -0.585 . . . . 2.49 109.951 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 12' ' ' LEU . 69.6 m-85 -130.84 119.52 22.35 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.576 -0.527 . . . . 1.34 109.576 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 21' ' ' GLN . 28.3 t -91.59 125.13 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 109.196 -0.668 . . . . 0.62 109.196 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.527 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 9.4 t30 50.04 23.07 1.02 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.421 -0.809 . . . . 1.86 110.314 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 54.8 53.9 36.63 Favored Glycine 0 N--CA 1.503 3.165 0 N-CA-C 108.575 -1.81 . . . . 0.81 108.575 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.538 ' HG3' ' HB3' ' A' ' 15' ' ' PRO . 1.4 tttt -159.19 -32.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.643 -0.502 . . . . 2.01 109.643 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 158' ' ' LYS . 44.6 m-85 -129.27 120.43 25.67 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.945 -0.702 . . . . 1.59 109.498 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 154' ' ' PHE . 14.3 pt20 -104.04 131.03 51.72 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.771 -0.455 . . . . 1.72 109.771 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 161' ' ' LEU . 17.4 mt -68.08 178.18 1.94 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 106.856 -1.535 . . . . 0.96 106.856 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -146.97 92.6 4.94 Favored Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 118.045 -1.462 . . . . 2.36 113.923 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -85.31 14.91 2.34 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.428 2.085 . . . . 1.74 108.132 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.41 -27.34 0.15 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.883 1.273 . . . . 3.9 113.583 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.32 52.29 0.29 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.639 -1.267 . . . . 3.72 111.663 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.87 89.03 3.05 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.195 0.998 . . . . 5.53 112.076 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -145.84 63.9 1.24 Allowed 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 105.691 -1.966 . . . . 5.3 105.691 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 169' ' ' SER . 18.4 p -95.14 -87.54 0.27 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.483 -0.761 . . . . 4.0 112.28 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.427 ' N ' ' OG1' ' A' ' 168' ' ' THR . 0.4 OUTLIER -163.47 26.52 0.08 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.374 -0.828 . . . . 3.0 109.92 -177.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -149.81 86.98 1.46 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 120.119 -0.632 . . . . 3.13 110.187 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.528 ' O ' HG23 ' A' ' 175' ' ' VAL . 49.0 mtt -68.68 -17.71 64.13 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.008 -1.478 . . . . 2.28 107.008 176.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -61.17 2.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.217 -0.66 . . . . 2.11 109.217 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 25.7 t -58.29 -38.63 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.763 -0.828 . . . . 1.39 108.763 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 174' ' ' PHE . 8.6 t80 -59.48 -49.47 77.68 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.843 -0.799 . . . . 2.72 108.843 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 171' ' ' MET . 84.9 t -67.84 -29.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 122.019 -0.426 . . . . 0.94 110.623 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -82.56 -53.84 5.64 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.281 -0.637 . . . . 2.49 109.281 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 0.8 OUTLIER -59.37 -40.42 86.42 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.719 -0.845 . . . . 2.75 108.719 179.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 5.0 t80 -62.6 -54.76 34.85 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.245 -1.021 . . . . 1.56 108.245 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.78 -28.5 66.01 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.749 -0.463 . . . . 0.76 109.749 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.31 -38.88 60.06 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.595 -0.52 . . . . 2.04 109.595 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.637 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -65.4 -39.22 91.94 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.809 -0.811 . . . . 1.1 108.809 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.91 -34.85 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 109.585 -0.524 . . . . 0.77 109.585 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -60.51 -52.31 65.72 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.337 -0.616 . . . . 2.47 109.337 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -36.84 64.56 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.566 -0.901 . . . . 1.54 108.566 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 181' ' ' THR . 0.5 OUTLIER -57.2 -22.76 43.0 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.834 -0.802 . . . . 0.91 108.834 -179.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.625 ' HB2' HG22 ' A' ' 54' ' ' VAL . 51.4 p -68.94 -28.91 67.07 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.098 -1.075 . . . . 1.31 108.098 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -92.54 24.77 3.33 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.627 -0.879 . . . . 2.68 108.627 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -59.5 -43.97 93.23 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.428 -0.509 . . . . 3.48 112.045 -177.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.4 pttp . . . . . 0 N--CA 1.501 2.09 0 CA-C-O 118.499 -0.762 . . . . 5.33 111.343 -177.355 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.735 ' HB1' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 122.355 1.074 . . . . 3.68 109.96 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.527 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -123.48 89.79 3.16 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.457 -2.053 . . . . 4.74 105.457 178.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 80.48 105.44 0.07 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 113.755 -1.566 . . . . 2.18 109.105 -177.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.735 ' HG3' ' HB1' ' A' ' 1' ' ' ALA . 23.8 mt-10 -125.82 50.3 1.86 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.951 0.882 . . . . 2.95 109.959 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 52.9 90.93 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.973 -0.558 . . . . 2.54 110.203 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.82 -19.0 21.64 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 110.637 -0.985 . . . . 1.2 110.637 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.85 -68.79 0.64 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.691 -1.226 . . . . 2.95 107.691 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -100.21 -22.09 15.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.105 -0.372 . . . . 3.41 110.895 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 1.5 p90 -154.81 119.76 4.91 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.821 0.82 . . . . 1.53 110.086 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 t -101.14 163.39 12.3 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.181 -1.044 . . . . 0.85 108.181 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.0 m -97.87 143.13 28.79 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.226 0.536 . . . . 1.04 110.261 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.495 HD21 ' CE1' ' A' ' 154' ' ' PHE . 2.6 mt -84.7 153.77 22.88 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.035 -0.53 . . . . 1.33 109.728 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -83.0 -20.26 35.42 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.5 -0.926 . . . . 3.32 108.5 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -125.62 100.95 30.86 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 109.605 -0.517 . . . . 2.92 109.605 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 37.3 Cg_endo -79.52 157.93 25.39 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.682 1.588 . . . . 1.24 109.093 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.1 t -119.85 104.92 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.314 0.578 . . . . 1.5 109.783 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.19 127.39 31.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.931 -1.137 . . . . 1.54 107.931 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.63 -14.7 64.71 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.373 -1.491 . . . . 1.15 109.373 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.527 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -45.36 158.61 0.31 Allowed Pre-proline 0 N--CA 1.507 2.387 0 CA-C-N 117.935 0.868 . . . . 0.84 111.045 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -78.85 140.12 16.01 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.289 1.993 . . . . 0.88 110.567 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.524 ' O ' HG13 ' A' ' 155' ' ' VAL . 2.6 mt-30 -53.02 -20.0 3.16 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 116.106 -0.497 . . . . 2.28 110.812 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 54.1 t -153.21 80.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.066 -1.087 . . . . 0.54 108.066 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.757 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -76.4 112.84 13.33 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.944 -1.502 . . . . 0.61 106.944 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -100.13 132.23 45.61 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.444 -0.576 . . . . 2.05 109.444 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.757 ' CE2' HD13 ' A' ' 23' ' ' LEU . 7.8 m-85 -118.3 119.23 34.01 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.223 -0.658 . . . . 1.26 109.223 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -155.84 143.57 19.6 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.827 -0.749 . . . . 1.35 109.662 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.778 ' HB3' HG22 ' A' ' 61' ' ' VAL . 3.3 p -118.47 167.12 11.89 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.238 -0.653 . . . . 1.25 109.238 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.566 ' O ' HG21 ' A' ' 96' ' ' VAL . 4.5 m-30 -91.66 53.07 2.16 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.667 -1.605 . . . . 1.35 106.667 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.629 ' CG ' HG11 ' A' ' 96' ' ' VAL . 8.8 m-85 -150.97 7.25 0.53 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.429 -0.805 . . . . 1.7 111.227 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 1.2 m -112.35 164.69 14.66 Favored Pre-proline 0 N--CA 1.495 1.796 0 CA-C-N 119.352 0.978 . . . . 1.05 110.124 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.16 -34.33 2.21 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 121.712 1.608 . . . . 0.78 108.322 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 36' ' ' PHE . 69.9 m80 -73.73 -39.79 64.02 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 107.448 -1.315 . . . . 2.92 107.448 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' A' ' 32' ' ' HIS . 6.5 t -29.57 -63.62 0.12 Allowed 'General case' 0 N--CA 1.52 3.031 0 CA-C-O 121.886 0.851 . . . . 1.67 110.685 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.569 ' HB2' ' OE1' ' A' ' 97' ' ' GLN . 16.1 t80 -66.29 -55.73 14.63 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.012 -0.995 . . . . 1.54 110.179 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -58.08 -18.97 28.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.631 -0.259 . . . . 1.88 111.165 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -87.22 -40.51 14.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.024 -0.422 . . . . 2.26 110.283 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.14 8.28 25.9 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.936 -0.478 . . . . 2.46 112.161 -177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 3.6 mm-40 -132.58 -40.82 0.97 Allowed 'General case' 0 N--CA 1.514 2.733 0 N-CA-C 113.654 0.983 . . . . 2.04 113.654 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.63 -70.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.23 -0.919 . . . . 1.17 111.017 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.44 -23.44 38.7 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 122.097 -0.377 . . . . 1.27 111.634 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 59.11 18.84 6.77 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.839 -0.538 . . . . 2.67 110.098 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.77 ' O ' HG13 ' A' ' 46' ' ' VAL . 32.0 mt -55.94 -23.0 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 121.436 -0.79 . . . . 0.88 110.083 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.82 -48.04 11.22 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 109.583 -0.525 . . . . 1.2 109.583 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.27 -28.57 57.12 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.803 -0.443 . . . . 2.71 109.803 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -69.51 -40.3 77.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.171 -0.33 . . . . 2.21 110.61 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 42' ' ' ILE . 7.5 m -68.72 -35.38 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.664 -0.814 . . . . 1.69 109.082 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.644 ' HA ' HD12 ' A' ' 50' ' ' LEU . 11.1 mttt -55.56 -38.42 69.31 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.956 -0.387 . . . . 2.11 109.956 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -37.11 65.96 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.886 -0.783 . . . . 3.72 108.886 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 20.4 mttt -103.19 33.25 3.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.8 -0.636 . . . . 3.17 110.943 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 47' ' ' LYS . 19.9 mt -108.33 92.7 10.13 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.583 -0.698 . . . . 1.62 109.198 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 32.9 Cg_endo -75.27 149.04 35.08 Favored 'Trans proline' 0 N--CA 1.484 0.929 0 C-N-CA 122.144 1.896 . . . . 1.84 110.612 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -44.32 120.21 2.1 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.72 0.771 . . . . 3.6 110.563 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.21 -19.83 5.98 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.173 -1.171 . . . . 1.34 110.173 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.625 HG22 ' HB2' ' A' ' 186' ' ' SER . 4.1 t -98.5 97.18 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.854 -0.792 . . . . 1.73 109.205 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -77.36 99.31 5.52 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.015 0.436 . . . . 2.91 110.049 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.504 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 10.3 ttt -93.16 102.11 14.41 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.498 -0.927 . . . . 2.26 108.498 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.36 142.06 33.32 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.517 -0.765 . . . . 0.56 109.118 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 113.65 20.76 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.587 -1.264 . . . . 2.48 107.587 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 4.0 m-85 -118.09 161.28 20.1 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.899 0.857 . . . . 1.28 112.129 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.676 ' NE2' HD23 ' A' ' 72' ' ' LEU . 55.6 t-80 -98.53 146.32 25.91 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.089 -0.96 . . . . 1.5 110.296 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.778 HG22 ' HB3' ' A' ' 27' ' ' SER . 3.3 m -96.33 156.63 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 115.042 -0.981 . . . . 1.44 110.827 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 70' ' ' LYS . 7.1 p-10 -127.53 48.25 2.26 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.013 0.911 . . . . 1.93 108.874 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -140.73 57.24 1.57 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.601 -1.629 . . . . 1.8 106.601 178.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.423 ' O ' ' HG3' ' A' ' 64' ' ' MET . 1.1 tpt -151.5 54.61 0.85 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.155 0.979 . . . . 3.48 109.836 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.5 -46.34 0.9 Allowed Glycine 0 N--CA 1.499 2.893 0 N-CA-C 109.544 -1.423 . . . . 2.39 109.544 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.28 -39.9 2.95 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.716 -0.954 . . . . 1.8 110.716 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.49 -80.22 0.26 Allowed 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 117.902 0.851 . . . . 2.03 110.69 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.712 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.37 -21.89 45.16 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.376 -0.529 . . . . 1.24 110.562 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.712 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -59.19 -37.65 92.07 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 108.584 -1.806 . . . . 0.49 108.584 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -69.92 -43.8 70.94 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.747 -0.835 . . . . 3.07 108.747 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -71.81 -27.82 63.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.863 -0.792 . . . . 1.67 108.863 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.748 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -69.45 -29.3 66.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.846 -1.168 . . . . 1.22 107.846 178.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.85 -43.13 94.01 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.851 -2.277 . . . . 0.43 104.851 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.843 ' O ' HG23 ' A' ' 78' ' ' VAL . 16.8 tt0 -60.64 -23.25 64.62 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.715 -1.217 . . . . 1.54 107.715 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.96 -48.72 75.37 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.986 -1.116 . . . . 0.49 107.986 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 36.3 t-105 -55.83 -34.78 65.7 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.467 -0.568 . . . . 0.85 109.467 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.36 -50.41 10.89 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.037 -0.665 . . . . 0.51 110.518 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.889 HG11 ' CD2' ' A' ' 122' ' ' TYR . 11.4 t -64.79 -26.75 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 122.093 -0.38 . . . . 0.83 110.565 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.9 -52.68 6.48 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.684 -0.858 . . . . 0.39 108.684 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.7 ttt -54.64 -25.98 30.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.751 -0.833 . . . . 1.51 108.751 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.881 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -68.77 -47.14 66.94 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.689 -0.486 . . . . 0.45 109.689 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 84' ' ' VAL . 38.9 mt -99.94 6.47 45.18 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.211 -0.306 . . . . 0.51 111.069 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.23 21.17 52.93 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.449 -1.46 . . . . 0.51 109.449 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.593 HG11 ' CG1' ' A' ' 117' ' ' ILE . 28.1 m -88.07 5.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 122.098 -0.648 . . . . 0.43 110.505 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' OE1' ' CH2' ' A' ' 76' ' ' TRP . 26.5 tt0 -49.82 -66.59 0.37 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.209 -0.663 . . . . 2.07 109.209 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.72 -35.35 1.8 Allowed 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 122.376 0.27 . . . . 1.36 111.404 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -78.58 -53.09 7.56 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 122.133 -0.354 . . . . 2.1 111.578 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.644 HG23 HD12 ' A' ' 92' ' ' LEU . 1.8 m -82.2 -11.41 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 O-C-N 121.8 -0.562 . . . . 0.38 110.949 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.71 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -71.85 -44.35 63.97 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.595 -0.891 . . . . 0.46 108.595 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -56.1 -55.91 36.67 Favored Pre-proline 0 N--CA 1.501 2.12 0 CA-C-O 118.359 -0.829 . . . . 0.53 110.211 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.643 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.1 Cg_endo -70.09 -19.31 34.7 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 O-C-N 123.377 1.198 . . . . 0.39 110.647 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' A' ' 111' ' ' VAL . 19.8 mt -85.49 -45.08 12.15 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.961 -0.755 . . . . 0.41 108.961 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' A' ' 89' ' ' THR . 4.0 m-30 -62.25 -48.04 81.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.887 -0.783 . . . . 1.24 108.887 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.54 -25.04 61.23 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.126 -0.488 . . . . 2.18 110.086 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.78 -27.85 62.08 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 111.116 -0.793 . . . . 0.37 111.116 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.2 t -96.02 -15.13 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 118.329 1.065 . . . . 0.49 110.196 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.569 ' OE1' ' HB2' ' A' ' 34' ' ' TYR . 25.2 mt-30 -112.55 1.84 16.01 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.073 -1.051 . . . . 2.3 113.432 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.808 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -152.48 47.41 0.74 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 119.583 1.083 . . . . 3.3 109.214 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.808 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -179.33 -48.6 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 115.959 -0.564 . . . . 1.27 109.884 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 99' ' ' THR . 3.2 mt-30 70.88 18.03 6.2 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 120.934 0.397 . . . . 1.71 110.1 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.7 t -82.78 -6.66 59.52 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.756 -0.831 . . . . 1.39 108.756 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.651 HG23 ' OD1' ' A' ' 107' ' ' ASP . 15.4 mm -90.1 79.06 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.977 -0.749 . . . . 0.44 108.977 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.98 25.78 1.91 Allowed 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.543 -0.723 . . . . 3.32 109.239 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.4 p -150.24 133.83 16.61 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.305 -0.628 . . . . 0.71 109.305 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.723 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -51.82 -33.47 35.98 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.325 -0.991 . . . . 0.59 108.325 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.5 p -62.94 -33.62 75.74 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.392 -0.966 . . . . 1.42 108.392 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.651 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -67.45 -49.79 62.1 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.836 -1.172 . . . . 1.94 107.836 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 105' ' ' ALA . 43.4 mt -49.45 -30.17 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 N-CA-C 109.04 -0.726 . . . . 0.53 109.04 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -74.2 -39.56 63.06 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.414 -0.587 . . . . 2.69 109.414 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.95 -45.08 78.93 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.523 -0.547 . . . . 2.21 109.523 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.807 HG11 ' HG ' ' A' ' 92' ' ' LEU . 21.7 t -71.86 -38.98 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 109.629 -0.508 . . . . 0.54 109.629 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -47.82 84.05 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.182 -0.673 . . . . 1.43 109.182 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.96 -25.71 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.724 -0.472 . . . . 0.49 109.724 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -25.8 68.19 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.835 -0.431 . . . . 1.72 109.835 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.9 6.84 33.64 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.991 -0.443 . . . . 0.63 110.256 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.12 7.21 73.94 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.996 -1.242 . . . . 0.72 109.996 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.648 HG22 ' HB2' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -90.72 64.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 107.2 -1.408 . . . . 0.91 107.2 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -41.71 147.44 0.2 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.415 -0.803 . . . . 2.69 110.918 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.31 -26.72 14.42 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 109.643 -1.383 . . . . 0.6 109.643 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -64.06 -47.94 78.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 122.276 -0.543 . . . . 2.4 109.67 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.83 -37.82 47.67 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.441 -0.577 . . . . 2.17 109.441 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.889 ' CD2' HG11 ' A' ' 78' ' ' VAL . 4.4 t80 -64.03 -51.12 65.66 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.61 -0.885 . . . . 1.45 108.61 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -61.97 -38.28 87.96 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.002 -0.74 . . . . 1.95 109.002 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.87 86.75 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.677 -0.86 . . . . 0.52 108.677 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.648 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -57.15 -54.3 48.29 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.689 -0.856 . . . . 0.47 108.689 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.415 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 13.9 t90 -53.53 -54.71 33.36 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.601 -0.889 . . . . 2.39 108.601 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -57.68 -16.55 11.13 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 116.012 -0.54 . . . . 1.46 111.104 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.6 m -74.64 -178.19 3.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.588 -0.695 . . . . 1.35 109.734 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.57 -40.7 11.8 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.832 -0.622 . . . . 3.19 111.1 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.46 -46.79 91.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.625 -0.83 . . . . 0.79 110.212 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.881 HG22 ' CB ' ' A' ' 81' ' ' ALA . 6.5 t -66.78 -37.08 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.7 -0.852 . . . . 0.82 108.7 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -68.59 -37.0 79.46 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.898 -0.779 . . . . 2.39 108.898 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.57 -33.97 76.02 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.901 -0.777 . . . . 1.43 108.901 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.57 -26.12 45.5 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.582 -0.895 . . . . 1.36 108.582 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.5 t -73.8 -48.28 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 107.3 -1.37 . . . . 0.64 107.3 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.69 -57.3 13.34 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.815 -0.809 . . . . 0.6 108.815 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.26 -21.61 62.09 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.407 -0.59 . . . . 2.43 109.407 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.451 ' OE1' ' HB3' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -71.74 -65.39 0.77 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.37 -0.974 . . . . 2.63 108.37 179.042 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -52.96 -30.55 35.44 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.748 -0.834 . . . . 2.56 108.748 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -72.56 -51.21 20.78 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.465 -0.939 . . . . 2.61 108.465 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -42.07 -56.95 2.64 Favored 'General case' 0 N--CA 1.508 2.473 0 CA-C-O 120.889 0.376 . . . . 0.65 110.592 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.94 -24.34 62.41 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.591 -0.443 . . . . 0.85 110.104 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -84.97 -21.13 29.66 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.874 -0.516 . . . . 1.05 111.49 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.38 -52.02 6.51 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 107.746 -1.205 . . . . 2.23 107.746 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.748 HG21 ' HE2' ' A' ' 25' ' ' PHE . 30.8 m -80.77 -20.75 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.354 -0.609 . . . . 0.92 109.354 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.6 OUTLIER 86.4 -43.65 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 123.079 0.552 . . . . 2.17 109.598 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 61' ' ' VAL . 56.6 tp 65.35 137.95 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.402 -0.962 . . . . 1.04 108.402 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.59 26.15 0.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 4.08 111.938 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.98 105.14 0.18 Allowed Glycine 0 N--CA 1.503 3.102 0 C-N-CA 119.908 -1.139 . . . . 0.72 110.977 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.519 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -87.19 139.51 32.29 Favored Pre-proline 0 N--CA 1.506 2.35 0 O-C-N 122.323 -0.516 . . . . 0.92 109.78 178.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -76.58 147.47 86.86 Favored 'Cis proline' 0 CA--C 1.545 1.028 0 O-C-N 123.193 1.102 . . . . 0.63 109.86 -0.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -131.47 150.07 52.29 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.183 -1.043 . . . . 0.57 108.183 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.475 ' SD ' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -139.63 139.66 36.76 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.239 -0.585 . . . . 2.49 109.951 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.495 ' CE1' HD21 ' A' ' 12' ' ' LEU . 69.6 m-85 -130.84 119.52 22.35 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.576 -0.527 . . . . 1.34 109.576 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 21' ' ' GLN . 28.3 t -91.59 125.13 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 109.196 -0.668 . . . . 0.62 109.196 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.527 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 9.4 t30 50.04 23.07 1.02 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.421 -0.809 . . . . 1.86 110.314 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 54.8 53.9 36.63 Favored Glycine 0 N--CA 1.503 3.165 0 N-CA-C 108.575 -1.81 . . . . 0.81 108.575 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.538 ' HG3' ' HB3' ' A' ' 15' ' ' PRO . 1.4 tttt -159.19 -32.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.643 -0.502 . . . . 2.01 109.643 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 158' ' ' LYS . 44.6 m-85 -129.27 120.43 25.67 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.945 -0.702 . . . . 1.59 109.498 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 154' ' ' PHE . 14.3 pt20 -104.04 131.03 51.72 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.771 -0.455 . . . . 1.72 109.771 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 161' ' ' LEU . 17.4 mt -68.08 178.18 1.94 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 106.856 -1.535 . . . . 0.96 106.856 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -146.97 92.6 4.94 Favored Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 118.045 -1.462 . . . . 2.36 113.923 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -85.31 14.91 2.34 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.428 2.085 . . . . 1.74 108.132 172.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.41 -27.34 0.15 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.883 1.273 . . . . 3.9 113.583 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.32 52.29 0.29 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.639 -1.267 . . . . 3.72 111.663 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.87 89.03 3.05 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.195 0.998 . . . . 5.53 112.076 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -145.84 63.9 1.24 Allowed 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 105.691 -1.966 . . . . 5.3 105.691 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 169' ' ' SER . 18.4 p -95.14 -87.54 0.27 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.483 -0.761 . . . . 4.0 112.28 -175.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.427 ' N ' ' OG1' ' A' ' 168' ' ' THR . 0.4 OUTLIER -163.47 26.52 0.08 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.374 -0.828 . . . . 3.0 109.92 -177.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -149.81 86.98 1.46 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 120.119 -0.632 . . . . 3.13 110.187 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.528 ' O ' HG23 ' A' ' 175' ' ' VAL . 49.0 mtt -68.68 -17.71 64.13 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.008 -1.478 . . . . 2.28 107.008 176.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -61.17 2.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.217 -0.66 . . . . 2.11 109.217 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 25.7 t -58.29 -38.63 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.763 -0.828 . . . . 1.39 108.763 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 174' ' ' PHE . 8.6 t80 -59.48 -49.47 77.68 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.843 -0.799 . . . . 2.72 108.843 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 171' ' ' MET . 84.9 t -67.84 -29.21 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 122.019 -0.426 . . . . 0.94 110.623 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -82.56 -53.84 5.64 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.281 -0.637 . . . . 2.49 109.281 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 0.8 OUTLIER -59.37 -40.42 86.42 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.719 -0.845 . . . . 2.75 108.719 179.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 5.0 t80 -62.6 -54.76 34.85 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.245 -1.021 . . . . 1.56 108.245 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.78 -28.5 66.01 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.749 -0.463 . . . . 0.76 109.749 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.31 -38.88 60.06 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.595 -0.52 . . . . 2.04 109.595 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.637 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -65.4 -39.22 91.94 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.809 -0.811 . . . . 1.1 108.809 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.91 -34.85 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 109.585 -0.524 . . . . 0.77 109.585 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -60.51 -52.31 65.72 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.337 -0.616 . . . . 2.47 109.337 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -36.84 64.56 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.566 -0.901 . . . . 1.54 108.566 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 181' ' ' THR . 0.5 OUTLIER -57.2 -22.76 43.0 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.834 -0.802 . . . . 0.91 108.834 -179.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.625 ' HB2' HG22 ' A' ' 54' ' ' VAL . 51.4 p -68.94 -28.91 67.07 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.098 -1.075 . . . . 1.31 108.098 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -92.54 24.77 3.33 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.627 -0.879 . . . . 2.68 108.627 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -59.5 -43.97 93.23 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.428 -0.509 . . . . 3.48 112.045 -177.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.4 pttp . . . . . 0 N--CA 1.501 2.09 0 CA-C-O 118.499 -0.762 . . . . 5.33 111.343 -177.355 . . . . . . . . 0 0 . 1 stop_ save_